SCHEMBL1021841

SCHEMBL1021841

O=C(O)OC1c2ccc(OCCN3CCCCC3)cc2CCN1S(=O)(=O)c1ccc(Oc2ccc(F)cc2)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 7/20 0.55
ESR2 Q92731 7/20 0.55
LTA4H P09960 1/20 0.47
HRH3 Q9Y5N1 5/20 0.47
HTR1A P08908 1/20 0.43
DRD2 P14416 1/20 0.43
HTR7 P34969 1/20 0.43
HTR6 P50406 1/20 0.43
FLT3 P36888 1/20 0.43
MMP1 P03956 3/20 0.42
MMP2 P08253 3/20 0.42
MMP7 P09237 3/20 0.42
MMP9 P14780 3/20 0.42
MMP12 P39900 3/20 0.42
MMP14 P50281 3/20 0.42
MMP15 P51511 3/20 0.42
MMP16 P51512 3/20 0.42
MMP26 Q9NRE1 3/20 0.42
CACNA1B Q00975 1/20 0.42
KDM4E B2RXH2 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1022530 0.92 ESR1 (0.47) ESR1ESR2HTR1ADRD2HTR7
SCHEMBL1023175 0.92 ESR1 (0.55) ESR1ESR2HRH3MMP1MMP2
SCHEMBL1021326 0.91 ESR1 (0.51) ESR1ESR2LTA4HHRH3HTR1A
SCHEMBL1022552 0.91 ESR1 (0.51) ESR1ESR2LTA4HHRH3HTR1A
SCHEMBL1021498 0.90 ESR1 (0.45) ESR1ESR2HRH3DRD2HTR6
SCHEMBL1021839 0.88 ESR1 (0.54) ESR1ESR2LTA4HHRH3HTR1A
SCHEMBL1020684 0.88 ESR1 (0.44) ESR1ESR2LTA4HHRH3HTR1A
SCHEMBL1019184 0.87 MMP1 (0.47) ESR1ESR2MMP1MMP2MMP7
SCHEMBL1021792 0.85 TBXAS1 (0.44) ESR1ESR2MMP1MMP2MMP7
SCHEMBL3535445 0.84 ESR1 (0.53) ESR1ESR2LTA4HHRH3HTR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1869001-B1 SUBSTITUTED TETRAHYDROISOCHINOLINES AS MMP INHIBITORS, RELATED PRODUCTION METHOD AND USE AS MEDICINE SANOFI AVENTIS (FR) 2011-01-12 EP disclosed
EP-1869001-A1 SUBSTITUTED TETRAHYDROISOCHINOLINES AS MMP INHIBITORS, RELATED PRODUCTION METHOD AND USE AS MEDICINE Sanofi-Aventis (FR) 2007-12-26 EP disclosed
WO-2006102998-A1 SUBSTITUTED TETRAHYDROISOCHINOLINES AS MMP INHIBITORS, RELATED PRODUCTION METHOD AND USE AS MEDICINE SANOFI-AVENTIS (DE) 2006-10-05 WO disclosed